Nicotinamide Mononucleotide (NMN) Market

Who Should Buy? Or Key Stakeholders

• Healthcare Industry
• Hospitals
• Pharmaceutical Industries
• Cosmetic Industries
• Chemical Industry
• Investors
• Manufacturing companies
• End user companies

Key Takeaways:

• The global nicotinamide mononucleotide (NMN) market grow at a CAGR of 8.2%
• Asia Pacific region is projected to show the largest market for NMN market.
• Based on type, content Above 98% is expected to dominate the market in this segment
• Based on application, Health Care Products is expected to dominate the market in this segment
• The Nicotinamide Mononucleotide (NMN) Market is witnessing growth due to increasing demand for anti-aging supplements and potential health benefits.

Nicotinamide Mononucleotide (NMN) Market Regional Analysis

The market for NMN region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

• North America: includes the US, Canada, Mexico
• Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
• Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
• South America: includes Brazil, Argentina and Rest of South America
• Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

Asia Pacific region is projected to show the largest market for NMN market. With the steady increase in the disposable income of Chinese residents and the dual impact of consumption upgrades and increased consumer awareness brought about by new digital media marketing, consumers' acceptance of NMN has gradually increased, and the demand for the NMN industry has accelerated. At present, domestic companies in this region have registered companies abroad or acquired nutritional products companies to develop NMN formulas and brands. After production is completed abroad, they can be sold to China through cross-border e-commerce channels.

[caption id="attachment_9250" align="alignnone" width="680"] Nicotinamide Mononucleotide (NMN) Market | Exactitude Consultancy[/caption]

Key Market Segments: NMN Market

NMN Market By Type, 2020-2029, ( USD Million) (Kilotons)

• Content Below 98%
• Content Above 98%

NMN Market By Application, 2020-2029, (USD Million) (Kilotons)

• Health Care Products
• Cosmetics

NMN Market by Region, 2020-2029, (USD Million) (Kilotons)

• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa

Important countries all regions are covered.

Key Question Answered

• What are the growth opportunities related to the adoption of NMN across major regions in the future?
• What are the new trends and advancements in the NMN market?

• Which product categories are expected to have highest growth rate in the NMN market?

• Which are the key factors driving the NMN market?
• What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?

Nicotinamide Mononucleotide (NMN) Market Segment Analysis

Nicotinamide Mononucleotide (NMN) market is segmented on the basis of type as content below 98% and content above 98%; on the base of application as health care products and cosmetics.

Nicotinamide Mononucleotide (NMN) Key Market Players

The key market players dominating the NMN market are GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, Bontac, Shandong Sihuan Pharmaceutical, EffePharm, Zhejiang Jiahua Pharmchemicals among others.

• Herbalmax focus on developing, manufacturing and licensing scientifically sound and clinically recognized natural dietary supplements.
• GeneHarbor (Hong Kong) Biotechnologies Limited is a biotechnology firm that manufactures a variety of enzymes for a variety of purposes.
• Shinkowa Pharmaceutical Co., Ltd. is a pharmaceutical company that has developed and sells dietary supplements and cosmetics.

1. Introduzione
   
   
   
   1. Definizione di mercato
   
   
   2. Segmentazione del mercato
   
   
   3. Cronologie della ricerca
   
   
   4. Presupposti e limitazioni
   
   
   
   


2. Metodologia di ricerca
   
   
   
   1. Estrazione dei dati
      
      
      
      1. Ricerca secondaria
      
      
      2. Ricerca primaria
      
      
      3. Consigli degli esperti in materia
      
      
      
      
   
   
   2. Controlli di qualità
      
      
      
      1. Revisione finale
      
      
      
      
   
   
   3. Triangolazione dei dati
      
      
      
      1. Approccio dal basso verso l'alto
      
      
      2. Approccio dall'alto verso il basso
      
      
      3. Flusso di ricerca
      
      
      
      
   
   
   4. Fonti dei dati
   
   
   
   


3. Sintesi


4. Panoramica del mercato
   
   
   
   1. Prospettive di mercato globali del mononucleotide di nicotinamide (NMN)
      
      
      
      1. Fattori trainanti del mercato
      
      
      2. Limitazioni di mercato
      
      
      3. Opportunità di mercato
      
      
      
      
   
   
   2. Impatto del Covid-19 sul mercato globale del mononucleotide di nicotinamide (NMN)
   
   
   
   


5. Mercato globale del mononucleotide di nicotinamide (NMN) per tipo, (milioni di USD) (chilotoni)
   
   
   
   1. Contenuto inferiore al 98%
   
   
   2. Contenuto superiore al 98%
   
   
   
   


6. Mercato globale del mononucleotide di nicotinamide (NMN) per applicazione, (milioni di USD) (chilotoni)
   
   
   
   1. Prodotti per la cura della salute
   
   
   2. Cosmetici
   
   
   
   


7. Mercato globale del mononucleotide di nicotinamide (NMN) per regione, (milioni di USD) (chilotoni)
   
   
   
   1. Introduzione
   
   
   2. Asia-Pacifico
      
      
      
      1. Cina
      
      
      2. India
      
      
      3. Giappone
      
      
      4. Corea del Sud
      
      
      5. Australia
      
      
      6. Asia sud-orientale
      
      
      7. Resto dell'Asia-Pacifico
      
      
      
      
   
   
   3. America del Nord
      
      
      
      1. Stati Uniti
      
      
      2. Canada
      
      
      3. Messico
      
      
      
      
   
   
   4. Europa
      
      
      
      1. Germania
      
      
      2. Regno Unito
      
      
      3. Francia
      
      
      4. Italia
      
      
      5. Spagna
      
      
      6. Russia
      
      
      7. Resto d'Europa
      
      
      
      
   
   
   5. Sud America
      
      
      
      1. Brasile
      
      
      2. Argentina
      
      
      3. Colombia
      
      
      4. Resto del Sud America
      
      
      
      
   
   
   6. Medio Oriente e Africa
      
      
      
      1. Emirati Arabi Uniti
      
      
      2. Arabia Saudita
      
      
      3. Sudafrica
      
      
      4. Resto del Medio Oriente e Africa
      
      
      
      
   
   
   
   


8. Profili aziendali * (Panoramica aziendale, Istantanea aziendale, Prodotti offerti, Sviluppi recenti)

• 
  
  
  
  1. GeneHarbor
  
  
  2. Erbemax
  
  
  3. Formule Genex
  
  
  4. Azienda farmaceutica Shinkowa
  
  
  5. Formule Maac10
  
  
  6. Bontac
  
  
  7. Farmaceutica Shandong Sihuan
  
  
  8. EffePharm
  
  
  9. Prodotti chimici farmaceutici di Zhejiang Jiahua
  
  
  10. Altri
  
  
  
  

*L'elenco delle aziende è indicativo

ELENCO DELLE TABELLE   

 

 



TABLE 1          GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 2          GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY 2020-2029

TABLE 3          GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 4          GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 5          GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 6          GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY REGION (KILOTONS) 2020-2029

TABLE 7          US NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 8          US NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 9          US NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 10        US NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 11        CANADA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 12        CANADA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 13        CANADA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 14        CANADA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 15        MEXICO NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 16        MEXICO NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 17        MEXICO NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 18        MEXICO NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 19        BRAZIL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 20        BRAZIL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 21        BRAZIL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 22        BRAZIL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 23        ARGENTINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 24        ARGENTINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 25        ARGENTINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 26        ARGENTINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 27        COLOMBIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 28        COLOMBIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 29        COLOMBIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 30        COLOMBIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 31        REST OF SOUTH AMERICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 32        REST OF SOUTH AMERICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 33        REST OF SOUTH AMERICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 34        REST OF SOUTH AMERICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 35        INDIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 36        INDIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 37        INDIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 38        INDIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 39        CHINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 40        CHINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 41        CHINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 42        CHINA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 43        JAPAN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 44        JAPAN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 45        JAPAN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 46        JAPAN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 47        SOUTH KOREA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 48        SOUTH KOREA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 49        SOUTH KOREA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 50        SOUTH KOREA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 51        AUSTRALIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 52        AUSTRALIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 53        AUSTRALIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 54        AUSTRALIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 55        SOUTH-EAST ASIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 56        SOUTH-EAST ASIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 57        SOUTH-EAST ASIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 58        SOUTH-EAST ASIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 59        REST OF ASIA PACIFIC NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 60        REST OF ASIA PACIFIC NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 61        REST OF ASIA PACIFIC NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 62        REST OF ASIA PACIFIC NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 63        GERMANY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 64        GERMANY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 65        GERMANY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 66        GERMANY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 67        UK NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 68        UK NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 69        UK NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 70        UK NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 71        FRANCE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 72        FRANCE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 73        FRANCE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 74        FRANCE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 75        ITALY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 76        ITALY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 77        ITALY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 78        ITALY NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 79        SPAIN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 80        SPAIN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 81        SPAIN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 82        SPAIN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 83        RUSSIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 84        RUSSIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 85        RUSSIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 86        RUSSIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 87        REST OF EUROPE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 88        REST OF EUROPE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 89        REST OF EUROPE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 90        REST OF EUROPE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 91        UAE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 92        UAE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 93        UAE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 94        UAE NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 95        SAUDI ARABIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 96        SAUDI ARABIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 97        SAUDI ARABIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 98        SAUDI ARABIA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 99        SOUTH AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 100      SOUTH AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 101      SOUTH AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 102      SOUTH AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

TABLE 103      REST OF MIDDLE EAST AND AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (USD MILLIONS) 2020-2029

TABLE 104      REST OF MIDDLE EAST AND AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE (KILOTONS) 2020-2029

TABLE 105      REST OF MIDDLE EAST AND AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 106      REST OF MIDDLE EAST AND AFRICA NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION (KILOTONS) 2020-2029

 

 

LIST OF FIGURES

FIGURE 1       MARKET DYNAMICS

FIGURE 2       MARKET SEGMENTATION

FIGURE 3       REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4       DATA TRIANGULATION

FIGURE 5       BOTTOM-UP APPROACH

FIGURE 6       TOP-DOWN APPROACH

FIGURE 7       RESEARCH FLOW

FIGURE 8       GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE, USD MILLION, 2020-2029

FIGURE 9       GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION, USD MILLION, 2020-2029

FIGURE 10    GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 11    PORTER’S FIVE FORCES MODEL

FIGURE 12    GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY TYPE 2020

FIGURE 13    GLOBAL NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY APPLICATION 2020

FIGURE 14    NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY REGION 2020

FIGURE 15    MARKET SHARE ANALYSIS

FIGURE 16    GENEHARBOR: COMPANY SNAPSHOT

FIGURE 17    HERBALMAX: COMPANY SNAPSHOT

FIGURE 18    GENEX FORMULAS: COMPANY SNAPSHOT

FIGURE 19    SHINKOWA PHARMACEUTICAL: COMPANY SNAPSHOT

FIGURE 20    MAAC10 FORMULAS: COMPANY SNAPSHOT

FIGURE 21    BONTAC: COMPANY SNAPSHOT

FIGURE 22     SHANDONG SIHUAN PHARMACEUTICAL: COMPANY SNAPSHOT

FIGURE 23     EFFEPHARM: COMPANY SNAPSHOT

FIGURE 24     ZHEJIANG JIAHUA PHARMCHEMICALS: COMPANY SNAPSHOT